A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropathy
Clinical trial NCT02994147 · COMPLETED
Trial details
- NCT number
- NCT02994147
- Sponsor
- TWi Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-21
- Primary completion
- 2019-04-18
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.